Julie Hambleton Igm Biosciences, Inc. (IGMS) insider trading activity

IGMS Quotes by TradingView

Julie Hambleton is of IGM Biosciences, Inc.. Currently has a direct ownership of 2,000 shares of IGMS, which is worth approximately $24,600. The most recent transaction as insider was on Jul 25, 2024, when has been sold 15,132 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $211,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2K
0% 3M change
0% 12M change
Total Value Held $24,600

Julie Hambleton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2024
SELL
Open market or private sale
$211,848 $14.0 p/Share
15,132 Reduced 88.33%
2,000 Common Stock
Jul 25 2024
BUY
Exercise of conversion of derivative security
$21,033 $1.39 p/Share
15,132 Added 46.9%
17,132 Common Stock
Aug 09 2021
SELL
Open market or private sale
$80,000 $80.0 p/Share
1,000 Reduced 33.33%
2,000 Common Stock
Jun 01 2021
SELL
Open market or private sale
$160,000 $80.0 p/Share
2,000 Reduced 40.0%
3,000 Common Stock

Also insider at

SWTX
SpringWorks Therapeutics, Inc. Healthcare
Director
ERAS
Erasca, Inc. Healthcare
Director
JH

Julie Hambleton

Stamford,, CT

Track Institutional and Insider Activities on IGMS

Follow IGM Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

News

Receive news related to IGM Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IGMS